CAS 910463-68-2

Product Description:

Product Name:  CAS NO: 910463-68-2

Synonyms:

Chemical & Physical Properties:

Appearance: White powder

Assay :≥99.0%

Long term Storage:-20 ± 5℃

We can provide GMP/DMF file support for this product, as well as other different standards to meet your different needs.

We can also provide the fillers used in the production process of semag+lutide synchronously:

SP FOCUROSE FF

DEAE FOCUROSE FF

Silica C8

It is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. it is a new generation GLP-1 (glucagon-like peptide-1) analogue developed by Novonordisk, Denmark. it is a long-acting dosage form based on the basic structure of liraglutide, which is better for the treatment of type 2 diabetes mellitus. Novo NorNord has completed six PChemicalbookhaseIIIa studies and has filed a new drug registration application with the U.S. Food and Drug Administration (FDA) on December 5, 2016 for somalutide once a week. An application for marketing authorisation (MAA) has also been submitted to the European Medicines Agency (EMA). Somalutide, on the other hand, is currently in Phase III clinical use in a once-daily oral formulation.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.